{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T21:01:43Z","timestamp":1790283703329,"version":"4.1.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,7,10]],"date-time":"2014-07-10T00:00:00Z","timestamp":1404950400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"funder":[{"DOI":"10.13039\/100004329","name":"Genzyme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004329","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["mgmjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1016\/j.ymgme.2014.07.005","type":"journal-article","created":{"date-parts":[[2014,7,12]],"date-time":"2014-07-12T22:15:11Z","timestamp":1405203311000},"page":"217-225","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"title":["Nonclinical safety assessment of recombinant human acid sphingomyelinase (rhASM) for the treatment of acid sphingomyelinase deficiency: The utility of animal models of disease in the toxicological evaluation of potential therapeutics"],"prefix":"10.1016","volume":"114","author":[{"given":"James M.","family":"Murray","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne Marie","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison","family":"Vitsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Hawes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Lien","family":"Chuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Pacheco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John M.","family":"McPherson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beth L.","family":"Thurberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth P.","family":"Karey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Andrews","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2014.07.005_bb0005","author":"Schuchman"},{"key":"10.1016\/j.ymgme.2014.07.005_bb0010","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/0005-2760(83)90218-7","article-title":"Biochemical studies in Niemann\u2013Pick disease, I, major sphingolipids of liver and spleen","volume":"750","author":"Vanier","year":"1983","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ymgme.2014.07.005_bb0015","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1148\/radiol.2381041696","article-title":"Type B Niemann\u2013Pick disease: findings at chest radiography, thin-section CT, and pulmonary function testing","volume":"238","author":"Mendelson","year":"2006","journal-title":"Radiology"},{"key":"10.1016\/j.ymgme.2014.07.005_bb0020","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/ng0795-288","article-title":"Acid sphingomyelinase deficient mice: a model of types A and B Niemann\u2013Pick disease","volume":"10","author":"Horinouchi","year":"1995","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ymgme.2014.07.005_bb0025","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0167-4838(99)00069-2","article-title":"Characterization of human acid sphingomyelinase purified from the media of overexpressing Chinese hamster ovary cells","volume":"1432","author":"He","year":"1999","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ymgme.2014.07.005_bb0030","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1074\/jbc.M309465200","article-title":"Mannose 6-phosphate receptor-mediated uptake is defective in acid sphingomyelinase-deficient macrophages: implications for Niemann\u2013Pick disease enzyme replacement therapy","volume":"279","author":"Dhami","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2014.07.005_bb0035","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1042\/bj3350465","article-title":"Signal transduction of stress via ceramide","volume":"335","author":"Mathias","year":"1998","journal-title":"Biochem. J."},{"key":"10.1016\/j.ymgme.2014.07.005_bb0040","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1096\/fj.00-0014com","article-title":"Infusion of recombinant human acid sphingomyelinase into Niemann\u2013Pick disease mice leads to visceral, but not neurological, correction of the pathophysiology","volume":"14","author":"Miranda","year":"2000","journal-title":"FASEB J."},{"key":"10.1016\/j.ymgme.2014.07.005_bb0045","series-title":"Clinical Textbook for Veterinary Technicians","first-page":"269","author":"McCurnin","year":"1998"},{"key":"10.1016\/j.ymgme.2014.07.005_bb0050","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.jhep.2008.01.026","article-title":"Ballooned hepatocytes in steatohepatitis: the value of keratin immunohistochemistry for diagnosis","volume":"48","author":"Lackner","year":"2008","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ymgme.2014.07.005_bb0055","series-title":"Harrison's Principles of Internal Medicine","first-page":"270","article-title":"Approach to the patient with shock","author":"Maier","year":"2011"},{"key":"10.1016\/j.ymgme.2014.07.005_bb0060","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1023\/A:1022998010833","article-title":"Induction of tolerance to a recombinant human enzyme, acid alpha-glucosidase, in enzyme deficient knockout mice","volume":"12","author":"Raben","year":"2003","journal-title":"Transgenic Res."},{"key":"10.1016\/j.ymgme.2014.07.005_bb0065","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1378\/chest.118.2.503","article-title":"Proinflammatory cytokines","volume":"118","author":"Dinarello","year":"2000","journal-title":"Chest"},{"key":"10.1016\/j.ymgme.2014.07.005_bb0070","doi-asserted-by":"crossref","DOI":"10.1186\/ar1917","article-title":"Interleukin-6 and chronic inflammation","volume":"8","author":"Gabay","year":"2006","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.ymgme.2014.07.005_bb0075","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1097\/shk.0b013e3180638d1","article-title":"Depressed heart rate variability is associated with high IL-6 blood level and decline in the blood pressure in septic patients","volume":"28","author":"Tateishi","year":"2007","journal-title":"Shock"},{"key":"10.1016\/j.ymgme.2014.07.005_bb0080","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1172\/JCI0216127","article-title":"The therapeutic potential of modulating the ceramide\/sphingomyelin pathway","volume":"110","author":"Kolesnick","year":"2002","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymgme.2014.07.005_bb0085","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1161\/hh2301.100350","article-title":"Sphingolipid mediators in cardiovascular cell biology and pathology","volume":"89","author":"Levade","year":"2001","journal-title":"Circ. Res."},{"key":"10.1016\/j.ymgme.2014.07.005_bb0090","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/nrc1411","article-title":"Biologically active sphingolipids in cancer pathogenesis and treatment","volume":"4","author":"Ogretmen","year":"2004","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ymgme.2014.07.005_bb0095","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1084\/jem.186.11.1831","article-title":"Lipopolysaccharide induces disseminated endothelial apoptosis requiring ceramide generation","volume":"186","author":"Haimovitz-Friedman","year":"1997","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ymgme.2014.07.005_bb0100","doi-asserted-by":"crossref","first-page":"5325","DOI":"10.1242\/jcs.02635","article-title":"Downregulation of the HERG (KCNH2) K+ channel by ceramide: evidence for ubiquitin-mediated lysosomal degradation","volume":"118","author":"Chapman","year":"2005","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.ymgme.2014.07.005_bb0105","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1084\/jem.20041685","article-title":"Role of membrane sphingomyelin and ceramide in platform formation for Fas-mediated apoptosis","volume":"202","author":"Miyaji","year":"2005","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ymgme.2014.07.005_bb0110","doi-asserted-by":"crossref","first-page":"7070","DOI":"10.1038\/sj.onc.1207146","article-title":"Raft ceramide in molecular medicine","volume":"22","author":"Gulbins","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.ymgme.2014.07.005_bb0115","doi-asserted-by":"crossref","first-page":"13839","DOI":"10.1074\/jbc.M311743200","article-title":"Sphingosine 1-phosphate (S1P) receptor subtypes S1P1 and S1P3, respectively, regulate lymphocyte recirculation and heart rate","volume":"279","author":"Sanna","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2014.07.005_bb0120","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1152\/ajpheart.00316.2007","article-title":"Mechanisms of the negative inotropic effects of sphingosine-1-phosphate on adult mouse ventricular myocytes","volume":"294","author":"Landeen","year":"2008","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.ymgme.2014.07.005_bb0125","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.bbalip.2008.04.003","article-title":"Sphingosine-1-phosphate signaling and biological activities in the cardiovascular system","volume":"1781","author":"Takuwa","year":"2008","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ymgme.2014.07.005_bb0130","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1161\/CIRCULATIONAHA.105.607135","article-title":"High-density lipoproteins and their constituent, sphingosine-1-phosphate, directly protect the heart against ischemia\/reperfusion injury in vivo via the S1P3 lysophospholipid receptor","volume":"114","author":"Theilmeier","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.ymgme.2014.07.005_bb0135","doi-asserted-by":"crossref","first-page":"4836","DOI":"10.1074\/jbc.272.8.4836","article-title":"Sphingosine mediates the immediate negative inotropic effects of tumor necrosis factor-alpha in the adult mammalian cardiac myocyte","volume":"272","author":"Oral","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2014.07.005_bb0140","first-page":"2291","article-title":"Depression of excitability by sphingosine 1-phosphate in rat ventricular myocytes","volume":"275","author":"MacDonell","year":"1998","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.ymgme.2014.07.005_bb0145","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1097\/PAS.0b013e31825793ff","article-title":"Liver and skin histopathology in adults with acid sphingomyelinase deficiency (Niemann\u2013Pick disease type B)","volume":"36","author":"Thurberg","year":"2012","journal-title":"Am. J. Surg. Pathol."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719214002091?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719214002091?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T16:52:36Z","timestamp":1538412756000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719214002091"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["S1096719214002091"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2014.07.005","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nonclinical safety assessment of recombinant human acid sphingomyelinase (rhASM) for the treatment of acid sphingomyelinase deficiency: The utility of animal models of disease in the toxicological evaluation of potential therapeutics","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2014.07.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}